AstraZeneca’s Imfinzi tees up small cell lung cancer fight with Roche

27th June 2019 Uncategorised 0

After Imfinzi’s key non-small cell lung cancer trial failure last year, AstraZeneca has some good news to report in lung cancer. But it’s from the much smaller field of small cell lung cancer where Roche’s Tecentriq is a step ahead.

More: AstraZeneca’s Imfinzi tees up small cell lung cancer fight with Roche
Source: fierce